323 related articles for article (PubMed ID: 34983357)
1. Immunometabolism in the Bladder Cancer Microenvironment.
Fattahi MJ; Haghshenas MR; Ghaderi A
Endocr Metab Immune Disord Drug Targets; 2022; 22(12):1201-1216. PubMed ID: 34983357
[TBL] [Abstract][Full Text] [Related]
2. Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy.
Zhang M; Wei T; Zhang X; Guo D
Front Immunol; 2022; 13():937406. PubMed ID: 36131916
[TBL] [Abstract][Full Text] [Related]
3. Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.
Nachef M; Ali AK; Almutairi SM; Lee SH
Front Immunol; 2021; 12():624324. PubMed ID: 33953707
[TBL] [Abstract][Full Text] [Related]
4. Therapeutically targeting essential metabolites to improve immunometabolism manipulation after liver transplantation for hepatocellular carcinoma.
Zhang W; Zhao Y; He Q; Lang R
Front Immunol; 2023; 14():1211126. PubMed ID: 37492564
[TBL] [Abstract][Full Text] [Related]
5. Targeting metabolism to enhance immunotherapy within tumor microenvironment.
Liang XH; Chen XY; Yan Y; Cheng AY; Lin JY; Jiang YX; Chen HZ; Jin JM; Luan X
Acta Pharmacol Sin; 2024 May; ():. PubMed ID: 38811773
[TBL] [Abstract][Full Text] [Related]
6. Effect of metabolism on the immune microenvironment of breast cancer.
Zhou Y; Wang H; Luo Y; Tuo B; Liu X; Li T
Biochim Biophys Acta Rev Cancer; 2023 Mar; 1878(2):188861. PubMed ID: 36813054
[TBL] [Abstract][Full Text] [Related]
7. HIF: a master regulator of nutrient availability and metabolic cross-talk in the tumor microenvironment.
Missiaen R; Lesner NP; Simon MC
EMBO J; 2023 Mar; 42(6):e112067. PubMed ID: 36808622
[TBL] [Abstract][Full Text] [Related]
8. [Metabolic Competition in Tumor Microenvironment].
Eikawa S; Udono H
Gan To Kagaku Ryoho; 2017 Nov; 44(11):972-976. PubMed ID: 29138369
[TBL] [Abstract][Full Text] [Related]
9. A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment.
Hofer F; Di Sario G; Musiu C; Sartoris S; De Sanctis F; Ugel S
Cells; 2021 Oct; 10(10):. PubMed ID: 34685679
[TBL] [Abstract][Full Text] [Related]
10. CD8
Castoldi A; Lee J; de Siqueira Carvalho D; Souto FO
Biochim Biophys Acta Mol Basis Dis; 2023 Jan; 1869(1):166565. PubMed ID: 36220587
[TBL] [Abstract][Full Text] [Related]
11. Discovering the strength of immunometabolism in cancer therapy: Employing metabolic pathways to enhance immune responses.
Huldani H; Malviya J; Rodrigues P; Hjazi A; Deorari MM; Al-Hetty HRAK; Qasim QA; Alasheqi MQ; Ihsan A
Cell Biochem Funct; 2024 Mar; 42(2):e3934. PubMed ID: 38379261
[TBL] [Abstract][Full Text] [Related]
12. Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting.
Yu YR; Ho PC
Clin Exp Immunol; 2019 Aug; 197(2):153-160. PubMed ID: 30873592
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of the Tumor Microenvironment That Influence Immune Cell Functions: Hypoxia, Oxidative Stress, Metabolic Alterations.
Augustin RC; Delgoffe GM; Najjar YG
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33348579
[TBL] [Abstract][Full Text] [Related]
14. Immunity, Hypoxia, and Metabolism-the Ménage à Trois of Cancer: Implications for Immunotherapy.
Riera-Domingo C; Audigé A; Granja S; Cheng WC; Ho PC; Baltazar F; Stockmann C; Mazzone M
Physiol Rev; 2020 Jan; 100(1):1-102. PubMed ID: 31414610
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral lipid metabolic reprogramming as a pro-tumoral regulator in the tumor milieu.
Wang R; Hu Q; Wu Y; Guan N; Han X; Guan X
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188962. PubMed ID: 37541532
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of Immune Cells in the Tumor Microenvironment.
Jung JG; Le A
Adv Exp Med Biol; 2021; 1311():173-185. PubMed ID: 34014543
[TBL] [Abstract][Full Text] [Related]
17. CD36-Fatty Acid-Mediated Metastasis via the Bidirectional Interactions of Cancer Cells and Macrophages.
Zaidi NE; Shazali NAH; Leow TC; Osman MA; Ibrahim K; Cheng WH; Lai KS; Nik Abd Rahman NMA
Cells; 2022 Nov; 11(22):. PubMed ID: 36428985
[TBL] [Abstract][Full Text] [Related]
18. Reshaping immunometabolism in the tumour microenvironment to improve cancer immunotherapy.
Chen S; Duan H; Sun G
Biomed Pharmacother; 2023 Aug; 164():114963. PubMed ID: 37269814
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Interactions in the Tumor Microenvironment.
Lyssiotis CA; Kimmelman AC
Trends Cell Biol; 2017 Nov; 27(11):863-875. PubMed ID: 28734735
[TBL] [Abstract][Full Text] [Related]
20. Immunometabolism: A new target for improving cancer immunotherapy.
Guo C; Chen S; Liu W; Ma Y; Li J; Fisher PB; Fang X; Wang XY
Adv Cancer Res; 2019; 143():195-253. PubMed ID: 31202359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
